A novel Antibiotic Preserves Gut Health

A novel approach in targeting Gram-negative infections without disrupting the microbiome

Topline

A groundbreaking study introduces lolamicin, a novel antibiotic targeting drug-resistant Gram-negative bacteria while sparing the gut microbiome. This new treatment option holds promise for both patients and healthcare providers by overcoming current drug resistance and reducing secondary infections.

Study Details

A recent study from the University…